Joao A M de Andrade MD

Interstitial Lung Diseases

Professor of Medicine, Vanderbilt University Medical Center

Summary

Joao de Andrade, MD is a Nashville-based Pulmonologist with subspecialty in Interstitial Lung Diseases. He was educated at the University of Alabama Medical Center and the University of Miami/Jackson Health System, and is now a Professor at Vanderbilt University Medical Center. He previously held positions at Birmingham VA Medical Center and University of Alabama Hospital. Dr. de Andrade currently serve as the Chief Medical Officer/Executive Medical Director of the Vanderbilt Lung Institute. He continues to be involved in clinical research and has a special interest in projects to improve clinical care and outcomes for patients battling interstitial lung disease. He has been recognized with various honors and awards for his contributions to teaching and his professional excellence.

University of Alabama Hospital (Birmingham)Fellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2000
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1994 - 1997
Federal University of Rio Grande do Sul School of MedicineClass of 1990

AOA Alpha Omega Alpha Honor Medical Society, 2018
Distinguished Chest Educator American College of Chest Physicians, 2017
CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2013-2017

PubMed

Journal Articles

Oxidative Modifications of Protein Tyrosyl Residues are Increased in Plasma of Human Subjects with Interstitial Lung Disease
Pennathur S, Vivekanandan-Giri A, Locy ML, Kulkarni T, Zhi D, Zeng L, Byun J, de Andrade J, Thannickal VJ, Am J Respir Crit Care Med, 1/17/2015
Pleiotropic Effect of the Proton Pump Inhibitor Esomeprazole Leading to Suppression of Lung Inflammation and Fibrosis
Ghebremarian YT, Cooke JP, Gerhart W, Griego C, Brower J, Doyle-Eisele M, Moeller BC, Zhou Q, Ho L, de Andrade J, Raghu G, Peterson L, Rivera A, Rosen GD, J Transl Med, 1/1/2015
The Idiopathic Pulmonary Fibrosis Clinical Research Network: Diagnostic and Adjudication Processes
de Andrade J, Schwarz M, Collard HR, Gentry-Bumpass T, Colby T, Lynch D, Kaner R; IPFnet Investigators, Chest, 1/1/2015

Books/Book Chapters

Interstitial Lung Disease
Chapter: Coagulation and Fibrinolysis in Lung Injury and Repair
de Andrade J, Olman MAEditors: Schwarz MI, King TE.People's Medical Publishing House, Shelton, CTEdition 5th,2011
Cecil Review of Internal Medicine
Chapter: Pulmonary Diseases
de Andrade JEditors: Cooper JAD, Pappas PG.Elsevier2004
Cancer-Integracao Clinico-Biologica
Chapter: O PDQ (Physician Data Query), um Sistema na Difusao de Formas Correntes e Experimentais para o Tratamento do Câncer
Robin H, Vinholes J, Machado V, de Andrade J.Editors: Fleck J.Artes Medicas1992

Abstracts/Posters

Clinical Characteristics and Disease Burden of Newly Diagnosed IPF at Tertiary Care Centers: Initial Results from the Idiopathic Pulmonary Fibrosis-PROspective Outcome...
Durheim M, O'Brien E, Gamerman V, Shrader P, Todd JL, Snyder L, Anstrom K, Belperio J, Culver D, de Andrade J, Roman J, Whelan TP, Palmer S, Conoscenti C, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
A Bundle of Care Improves Outcomes in Idiopathic Pulmonary Fibrosis
Kulkarni T, Acosta Lara P, Willoughby J, Kim Y, Ramachandran R, Alexander CB, Luckhardt T, Thannickal VJ, de Andrade J, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015
Next Generation Sequencing Does Not Support a Causative Role for Herpes Virus in IPF
Lasky J, Yin Q, Flemington E, Zhu D, Kaminski N, de Andrade J, Pulmonary Fibrosis Summit, Washington DC, 1/1/2015

Lectures

Idiopathic Pulmonary Fibrosis
1/1/2015
Non-pharmacological management of Idiopathic Pulmonary Fibrosis
Montreal, QC, Canada - 1/1/2015
Clinical Aspects of Other Interstitial Lung Diseases (Non-granulomatous)
1/1/2011